Value of serum procalcitonin as an early predictor of antibiotic treatment response in inpatients with pelvic inflammatory disease (VALID)
Objective: This study aimed to investigate the value of serum procalcitonin as an early predictor of antibiotic treatment response in the inpatient management of pelvic inflammatory disease (PID). Materials and methods: A prospective observational study was carried out at a university hospital. Pati...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Taiwanese Journal of Obstetrics & Gynecology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1028455920301601 |
_version_ | 1818215601846353920 |
---|---|
author | In Kyung Hong Min-Jung Kwon Su Hyun Nam Kye Hyun Kim Kyo Won Lee Ji-Hee Sung Taejong Song |
author_facet | In Kyung Hong Min-Jung Kwon Su Hyun Nam Kye Hyun Kim Kyo Won Lee Ji-Hee Sung Taejong Song |
author_sort | In Kyung Hong |
collection | DOAJ |
description | Objective: This study aimed to investigate the value of serum procalcitonin as an early predictor of antibiotic treatment response in the inpatient management of pelvic inflammatory disease (PID). Materials and methods: A prospective observational study was carried out at a university hospital. Patients admitted for pelvic inflammatory disease were classified into 2 groups: responders and non-responders. The primary outcome measure was the serum level of procalcitonin at the time of admission. The secondary outcome measures were other serum inflammatory markers including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cell (WBC) count. Results: Baseline characteristics were similar between the groups. Serum level of procalcitonin at the time of admission did not differ between the groups (P = 0.564). However, the non-responders had more elevated CRP and ESR compared to the responders (P = 0.045 and P = 0.030, respectively). CRP showed the highest accuracy of 72.1% (95% confidence interval [CI], 59.2 to 82.9) in predicting antibiotics response, while procalcitonin showed the lowest accuracy of 49.1% (95% CI, 35.1 to 63.2). Conclusion: Compared with standard inflammatory markers such as CRP or ESR, procalcitonin had limited diagnostic value in predicting antibiotics response in patients admitted for PID. Therefore, procalcitonin measurement cannot be recommended as a laboratory test for patients with PID and the value of its routine use remains inconclusive. |
first_indexed | 2024-12-12T06:38:41Z |
format | Article |
id | doaj.art-312f8d08455e455fa38401d3269e3833 |
institution | Directory Open Access Journal |
issn | 1028-4559 |
language | English |
last_indexed | 2024-12-12T06:38:41Z |
publishDate | 2020-09-01 |
publisher | Elsevier |
record_format | Article |
series | Taiwanese Journal of Obstetrics & Gynecology |
spelling | doaj.art-312f8d08455e455fa38401d3269e38332022-12-22T00:34:24ZengElsevierTaiwanese Journal of Obstetrics & Gynecology1028-45592020-09-01595660664Value of serum procalcitonin as an early predictor of antibiotic treatment response in inpatients with pelvic inflammatory disease (VALID)In Kyung Hong0Min-Jung Kwon1Su Hyun Nam2Kye Hyun Kim3Kyo Won Lee4Ji-Hee Sung5Taejong Song6Department of Obstetrics & Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Laboratory Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Obstetrics & Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Obstetrics & Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Obstetrics & Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Obstetrics & Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Obstetrics & Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Corresponding author. Department of Obstetrics and Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181, Republic of Korea. Fax: +82 2 2001 1102.Objective: This study aimed to investigate the value of serum procalcitonin as an early predictor of antibiotic treatment response in the inpatient management of pelvic inflammatory disease (PID). Materials and methods: A prospective observational study was carried out at a university hospital. Patients admitted for pelvic inflammatory disease were classified into 2 groups: responders and non-responders. The primary outcome measure was the serum level of procalcitonin at the time of admission. The secondary outcome measures were other serum inflammatory markers including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cell (WBC) count. Results: Baseline characteristics were similar between the groups. Serum level of procalcitonin at the time of admission did not differ between the groups (P = 0.564). However, the non-responders had more elevated CRP and ESR compared to the responders (P = 0.045 and P = 0.030, respectively). CRP showed the highest accuracy of 72.1% (95% confidence interval [CI], 59.2 to 82.9) in predicting antibiotics response, while procalcitonin showed the lowest accuracy of 49.1% (95% CI, 35.1 to 63.2). Conclusion: Compared with standard inflammatory markers such as CRP or ESR, procalcitonin had limited diagnostic value in predicting antibiotics response in patients admitted for PID. Therefore, procalcitonin measurement cannot be recommended as a laboratory test for patients with PID and the value of its routine use remains inconclusive.http://www.sciencedirect.com/science/article/pii/S1028455920301601Pelvic inflammatory diseaseTuboovarian abscessProcalcitoninC-reactive protein |
spellingShingle | In Kyung Hong Min-Jung Kwon Su Hyun Nam Kye Hyun Kim Kyo Won Lee Ji-Hee Sung Taejong Song Value of serum procalcitonin as an early predictor of antibiotic treatment response in inpatients with pelvic inflammatory disease (VALID) Taiwanese Journal of Obstetrics & Gynecology Pelvic inflammatory disease Tuboovarian abscess Procalcitonin C-reactive protein |
title | Value of serum procalcitonin as an early predictor of antibiotic treatment response in inpatients with pelvic inflammatory disease (VALID) |
title_full | Value of serum procalcitonin as an early predictor of antibiotic treatment response in inpatients with pelvic inflammatory disease (VALID) |
title_fullStr | Value of serum procalcitonin as an early predictor of antibiotic treatment response in inpatients with pelvic inflammatory disease (VALID) |
title_full_unstemmed | Value of serum procalcitonin as an early predictor of antibiotic treatment response in inpatients with pelvic inflammatory disease (VALID) |
title_short | Value of serum procalcitonin as an early predictor of antibiotic treatment response in inpatients with pelvic inflammatory disease (VALID) |
title_sort | value of serum procalcitonin as an early predictor of antibiotic treatment response in inpatients with pelvic inflammatory disease valid |
topic | Pelvic inflammatory disease Tuboovarian abscess Procalcitonin C-reactive protein |
url | http://www.sciencedirect.com/science/article/pii/S1028455920301601 |
work_keys_str_mv | AT inkyunghong valueofserumprocalcitoninasanearlypredictorofantibiotictreatmentresponseininpatientswithpelvicinflammatorydiseasevalid AT minjungkwon valueofserumprocalcitoninasanearlypredictorofantibiotictreatmentresponseininpatientswithpelvicinflammatorydiseasevalid AT suhyunnam valueofserumprocalcitoninasanearlypredictorofantibiotictreatmentresponseininpatientswithpelvicinflammatorydiseasevalid AT kyehyunkim valueofserumprocalcitoninasanearlypredictorofantibiotictreatmentresponseininpatientswithpelvicinflammatorydiseasevalid AT kyowonlee valueofserumprocalcitoninasanearlypredictorofantibiotictreatmentresponseininpatientswithpelvicinflammatorydiseasevalid AT jiheesung valueofserumprocalcitoninasanearlypredictorofantibiotictreatmentresponseininpatientswithpelvicinflammatorydiseasevalid AT taejongsong valueofserumprocalcitoninasanearlypredictorofantibiotictreatmentresponseininpatientswithpelvicinflammatorydiseasevalid |